2[3]Otis DR, Johnson M, Pedley TJ, et al. Role of pulmonary surfactant in airway closure : A computational study. J Appl Physiol, 1993, 75(3): 1323- 1333.
3[4]Hohlfeld J, Tiryaki E, Hamn H, et al. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Med, 1998, 158(3): 706- 712.
4[5]McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, or chestrate innate immunity in the lung. J Clin Invest, 2002, 109(6): 707- 712.
5[6]Kremlev SG, Umstead TM, Phelp DS. Surfactant protein A egulates cytokine production in the monocytic cell line THP-1. Am J Physiol, 1997, 272( 5pt 1): L996 - 1004.
6[7]Augusto LA, Li J, Synguelakis M, et al. Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem, 2002, 277(26): 23484- 23492.
7[8]Harrod KS, Trapnell BC, Otaka K, et al. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am J Physiol, 1999, 277(3pt1): L580- 588.
